Home » Acute myeloid leukemia, Aifa approves new innovative therapy

Acute myeloid leukemia, Aifa approves new innovative therapy

by admin

(beraking latest news) – The press conference entitled ‘Acute Myeloid Leukemia: new perspectives in the management of the disease’ was held in Rome. The event was attended by numerous experts in the sector who were able to illustrate the news regarding an aggressive hematological disease which affects around 3,300 people in Italy every year, most of whom are elderly patients. Among the novelties, it is worth mentioning the green light by AIFA for the reimbursement of the drug Venetoclax in combination with azacitidine for those who are not suitable for standard intensive chemotherapy. The drug extends survival by 15 months.

See also  Iss: Delta variant growing, comply with the measures - Health

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy